Notice of AGM

31 March 2023

IMPACT HEALTHCARE REIT PLC

("Impact" or the "Company" or, together with its subsidiaries, the "Group")

2023 Notice of Annual General Meeting

The Board of Directors of Impact Healthcare REIT plc (ticker: IHR), the real estate investment trust which gives investors exposure to a diversified portfolio of UK healthcare real estate assets, in particular care homes, is pleased to announce that the 2023 Notice of Annual General Meeting is now available to view on the Company's website at https://www.impactreit.uk/investors/reporting-centre/.  

The Company's Annual General Meeting will be held at 11.00 a.m. on Wednesday, 17 May 2023, at the offices of Travers Smith LLP, 10 Snow Hill, London EC1A 2AL.

The formal Notice of the Annual General Meeting will be posted to those shareholders who have requested that the Company should continue with postal correspondence and in accordance with Listing Rule 9.6.1 has been submitted to the Financial Conduct Authority and will shortly be available for inspection from the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

This year's Annual General Meeting will follow its usual format as the Board considers it important that Shareholders continue to have opportunities to engage with it.

The Board also encourages Shareholders to vote on any of the matters of business at the AGM in advance by proxy.

If circumstances change before the AGM, the Company will consider making appropriate changes and if it is appropriate notify shareholders of any changes to the proposed format for the AGM as soon as possible via RIS and its website (https://www.impactreit.uk/investors/reporting-centre/).

FOR FURTHER INFORMATION, PLEASE CONTACT:

The Company's LEI is 213800AX3FHPMJL4IJ53.

Further information on Impact Healthcare REIT is available at www.impactreit.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END